Literature DB >> 27439620

A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.

Ahmad Y Abuhelwa1,2, David J R Foster3, Richard N Upton3.   

Abstract

This study aimed to conduct a quantitative meta-analysis for the values of, and variability in, gastrointestinal (GI) transit times of non-disintegrating single-unit ("tablet") and multiple-unit ("pellets/multi-unit tablet") solid dosage forms, characterize the effect of food on the values and variability in these parameters and present quantitative meta-models of the distributions of GI transit times in the respective GI regions to help inform models of oral drug absorption. The literature was systemically reviewed for the values of, and the variability in, gastric, small intestinal and colonic transit times under fed and fasted conditions. Meta-analysis used the "metafor" package of the R language. Meta-models of GI transit were assumed to be log-normally distributed between the studied populations. Twenty-nine studies including 125 reported means and standard deviations were used in the meta-analysis. Caloric content of administered food increased variability and delayed the gastric transit of both pellets and tablets. Conversely, food caloric content reduced the variability but had no significant influence on the mean small intestinal transit time (SITT). Food had no significant effect on the transit time through the colon. The transit of pellets through the colon was significantly slower than that of single-unit tablets which is most likely related to their smaller size. GI transit times may influence the dissolution and absorption of oral drugs. The meta-models of GI transit times may be used as part of semi-physiological absorption models to characterize the influence of transit time on the dissolution, absorption and in vivo pharmacokinetic profiles of oral drugs.

Entities:  

Keywords:  colonic transit time; gastric emptying; gastrointestinal transit time; meta-analysis; small intestinal transit time

Mesh:

Year:  2016        PMID: 27439620     DOI: 10.1208/s12248-016-9953-7

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  47 in total

Review 1.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

2.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

3.  Effect of the menstrual cycle on gastric emptying.

Authors:  R C Gill; P D Murphy; H R Hooper; K L Bowes; Y J Kingma
Journal:  Digestion       Date:  1987       Impact factor: 3.216

4.  Gastric emptying of large single unit dosage forms.

Authors:  S S Davis; F Norring-Christensen; R Khosla; L C Feely
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

5.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

6.  Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System.

Authors:  Mirko Koziolek; Michael Grimm; Dieter Becker; Ventzeslav Iordanov; Hans Zou; Jeff Shimizu; Christoph Wanke; Grzegorz Garbacz; Werner Weitschies
Journal:  J Pharm Sci       Date:  2014-11-19       Impact factor: 3.534

7.  Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.

Authors:  I R Wilding; S S Davis; M Bakhshaee; H N Stevens; R A Sparrow; J Brennan
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

8.  Effects of essential and nonessential amino acids on gastric emptying in the dog.

Authors:  J R Stephens; R F Woolson; A R Cooke
Journal:  Gastroenterology       Date:  1975-10       Impact factor: 22.682

9.  Reduced ampicillin bioavailability following oral coadministration with chloroquine.

Authors:  H M Ali
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

10.  Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets.

Authors:  Jacoba M Maurer; Reinout C A Schellekens; Hèlen M van Rieke; Christoph Wanke; Ventzeslav Iordanov; Frans Stellaard; Klaus D Wutzke; Gerard Dijkstra; Margot van der Zee; Herman J Woerdenbag; Henderik W Frijlink; Jos G W Kosterink
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more
  9 in total

Review 1.  A Review of Food-Drug Interactions on Oral Drug Absorption.

Authors:  Jianyuan Deng; Xiao Zhu; Zongmeng Chen; Chun Ho Fan; Him Shek Kwan; Chi Ho Wong; Ka Yi Shek; Zhong Zuo; Tai Ning Lam
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

2.  Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-04       Impact factor: 2.441

3.  Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models.

Authors:  Pavlos Chryssafidis; Athanasios A Tsekouras; Panos Macheras
Journal:  Pharm Res       Date:  2022-04-04       Impact factor: 4.200

4.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009

5.  Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; Richard N Upton; David J R Foster
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-11-17       Impact factor: 2.745

6.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

Review 7.  Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release.

Authors:  Ioannis Nikolakakis; Ioannis Partheniadis
Journal:  Pharmaceutics       Date:  2017-11-03       Impact factor: 6.321

Review 8.  In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.

Authors:  Mauricio A García; Felipe Varum; Jozef Al-Gousous; Michael Hofmann; Susanne Page; Peter Langguth
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

9.  Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery.

Authors:  Annemarie Broesder; Said Y Bircan; Anneko B de Waard; Anko C Eissens; Henderik W Frijlink; Wouter L J Hinrichs
Journal:  Pharmaceutics       Date:  2021-11-23       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.